Trial Profile
Evaluation of efficacy of epinastine hydrochloride ophthalmic solution for allergic conjunctival diseases in the senior persons.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2022
Price :
$35
*
At a glance
- Drugs Epinastine (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- 09 Feb 2014 New trial record